Evidence map›Paper›PMID 30944221›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity.

Keith Allen-Redpath, Maceler Aldrovandi, Sarah N Lauder, Anastasia Gketsopoulou, Victoria J Tyrrell, David A Slatter, Robert Andrews, W John Watkins, Georgia Atkinson, Eileen McNeill and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. 12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  8. Lipoxin AbioRxiv : the preprint server for biology · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 2 countries.

Keith Allen-RedpathSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Maceler AldrovandiSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Sarah N LauderSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Anastasia GketsopoulouSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Victoria J TyrrellSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
David A SlatterSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Robert AndrewsSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
W John WatkinsSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Georgia AtkinsonSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Eileen McNeillDivision of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, Radcliffe Department of Medicine, University of Oxford, OX3 9DU Oxford, United Kingdom.
Anna GilfedderSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Majd ProttySystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
James BurstonSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Sam R C JohnsonSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Patricia R S RodriguesSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Dylan O JonesSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Regent LeeNuffield Department of Surgical Sciences, University of Oxford, OX3 9DU Oxford, United Kingdom.
Ashok HandaNuffield Department of Surgical Sciences, University of Oxford, OX3 9DU Oxford, United Kingdom.
Keith ChannonDivision of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, Radcliffe Department of Medicine, University of Oxford, OX3 9DU Oxford, United Kingdom.
Samya ObajiSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Jorge Alvarez-JarretaSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Gerhard KrönkeDepartment of Internal Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.
Jochen AckermannDepartment of Internal Medicine, University Hospital Erlangen, 91054 Erlangen, Germany.
P Vince JenkinsHaematology Department, University Hospital of Wales, CF14 4XW Cardiff, United Kingdom.
Peter W CollinsSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom.
Valerie B O'DonnellSystems Immunity Research Institute, School of Medicine, Cardiff University, CF14 4XN Cardiff, United Kingdom; o-donnellvb@cardiff.ac.uk.ORCID 0000-0003-4089-8460
Cardiff University · GBBritish Heart Foundation · GBUniversitätsklinikum Erlangen · DEUniversity of Oxford · GBUniversity Hospital of Wales · GB

Funding

British Heart Foundation CH/16/1/32013British Heart Foundation FS/16/20/32005British Heart Foundation RG/07/003/23133British Heart Foundation RG/12/11/29815British Heart Foundation RG/12/5/29576British Heart Foundation RG/13/1/30181British Heart Foundation RG/15/10/31485British Heart Foundation RG/17/10/32859Wellcome TrustWellcome Trust 094143/Z/10/ZWellcome Trust 203014/Z/16/Z
6 · The paper itself

Abstract

Abdominal aortic aneurysm (AAA) is an inflammatory vascular disease with high mortality and limited treatment options. How blood lipids regulate AAA development is unknown. Here lipidomics and genetic models demonstrate a central role for procoagulant enzymatically oxidized phospholipids (eoxPL) in regulating AAA. Specifically, through activating coagulation, eoxPL either promoted or inhibited AAA depending on tissue localization. Ang II administration to

Indexed as

Aortic Aneurysm, AbdominalPhospholipidsAngiotensinsAnimalsAorta, AbdominalBlood Coagulation FactorsDisease Models, AnimalFemaleLipoxygenaseMaleMiceMice, Knockout, ApoEAngiotensinsBlood Coagulation FactorsLipoxygenasePhospholipidsaneurysmangiotensinlipidlipoxygenasephospholipid

Identifiers

PMID30944221
PMCPMC6475397
OpenAlexW2927894892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.